{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:03:28Z","timestamp":1790337808103,"version":"4.1.0"},"reference-count":101,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Endometrial cancer (EC) is the most common gynecological malignancy in developed countries, with rising incidence rates that have not been matched by equivalent improvements in survival outcomes, particularly for high-grade and advanced-stage disease. The landmark molecular profiling performed by The Cancer Genome Atlas consortium transformed EC classification by identifying four reproducible subtypes with distinct prognostic profiles: POLE-ultramutated, mismatch repair-deficient, copy-number low, and copy-number high. This reclassification has directly informed clinical guidelines, and, most recently, enabled three practice-changing regulatory approvals that established chemoimmunotherapy as a new first-line treatment paradigm for advanced disease, although regulatory indications differ according to MMR status. Yet molecular heterogeneity within EC involves much more than just genomic alterations to encompass coordinated changes in developmental signaling pathways, subcellular protein redistribution, epigenetic regulation, and tumor\u2013immune crosstalk. This narrative review synthesizes current evidence across several interconnected dimensions of EC biology: aberrant WNT\/\u03b2-catenin and mTOR signaling with compartment-specific expression patterns; cancer stem cell markers, including CD133, SOX2, and OCT4; \u03b3-glutamyl transferase as a redox-linked biomarker; NOTCH pathway dysregulation, whose context-dependent, occasionally paradoxical relationship with prognosis complicates direct translation of NOTCH-targeted therapies from other tumor types; an expanded landscape of tissue and circulating microRNAs for grade discrimination and prognosis, extending well beyond our own previously reported miR-375\/miR-190b panel; and the prognostic and therapeutic relevance of tumor-infiltrating lymphocytes, together with T-cell receptor repertoire profiling as an emerging complementary immune biomarker. We also discuss emerging frontiers, including circulating tumor DNA as a minimal residual disease tool, single-cell and spatial transcriptomics revealing tumor microenvironment architecture, and artificial intelligence-augmented digital pathology. Building on these axes, we propose an integrated conceptual model in which developmental signaling, subcellular protein trafficking, epigenetic and stemness reprogramming, and immune remodeling are mechanistically coupled, rather than independent processes. A multidimensional, integrative framework incorporating these axes is essential for bridging the current gap between biological complexity and clinical precision in EC.<\/jats:p>","DOI":"10.3389\/fonc.2026.1906951","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:40:41Z","timestamp":1790336441000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond molecular classification: integrating signaling, subcellular, and immune reprogramming in endometrial cancer"],"prefix":"10.3389","volume":"16","author":[{"given":"Mi\u0142osz","family":"Pietrus","sequence":"first","affiliation":[{"name":"Department of Gynecology and Oncology, Faculty of Medicine, Jagiellonian University Medical College","place":["Krak\u00f3w, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Walig\u00f3ra","sequence":"additional","affiliation":[{"name":"Pulmonary Circulation Centre, Department of Cardiac and Vascular Diseases, Faculty of Medicine, Jagiellonian University Medical College, John Paul II Hospital in Krak\u00f3w","place":["Krak\u00f3w, Poland"]},{"name":"Center for Innovative Medical Education, Department of Medical Education, Faculty of Medicine, Jagiellonian University Medical College","place":["Krak\u00f3w, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej W.","family":"Socha","sequence":"additional","affiliation":[{"name":"Department of Perinatology, Gynecology and Gynecologic Oncology, Faculty of Health Sciences, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University","place":["Bydgoszcz, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaudia","family":"Skrzypek","sequence":"additional","affiliation":[{"name":"Department of Transplantation, Institute of Pediatrics, Faculty of Medicine, Jagiellonian University Medical College","place":["Krak\u00f3w, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Kabzinska-Turek","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Oncology, Faculty of Medicine, Jagiellonian University Medical College","place":["Krak\u00f3w, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene","family":"Laky","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynecology, Medical University of Graz","place":["Graz, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Gawron","sequence":"additional","affiliation":[{"name":"Chair of Gynecology and Obstetrics, Faculty of Medicine, Jagiellonian University Medical College","place":["Krak\u00f3w, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00130-0","article-title":"Endometrial cancer","volume":"387","author":"Morice","year":"2016","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-010-9612-8","article-title":"Factors associated with Type I and Type II endometrial cancer","volume":"21","author":"Felix","year":"2010","journal-title":"Cancer Causes Control"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0020-7292(06)60031-3","article-title":"Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynaecological Cancer","volume":"95","author":"Creasman","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"B5","unstructured":"Survival Rates for Endometrial Cancer\n          \n          2025"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(83)90111-7","article-title":"Two pathogenetic types of endometrial carcinoma","volume":"15","author":"Bokhman","year":"1983","journal-title":"Gynecol Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Levine","year":"2013","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30496","article-title":"Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer","volume":"123","author":"Talhouk","year":"2017","journal-title":"Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2216334","article-title":"Dostarlimab for primary advanced or recurrent endometrial cancer","volume":"388","author":"Mirza","year":"2023","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2302312","article-title":"Pembrolizumab plus chemotherapy in advanced endometrial cancer","volume":"388","author":"Eskander","year":"2023","journal-title":"N Engl J Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.02132","article-title":"Durvalumab plus carboplatin\/paclitaxel followed by maintenance durvalumab with or without olaparib as first-line treatment for advanced endometrial cancer: the phase III DUO-E trial","volume":"42","author":"Westin","year":"2024","journal-title":"J Clin Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/854056","article-title":"Participation of WNT and \u03b2-catenin in physiological and pathological endometrial changes: association with angiogenesis","volume":"2015","author":"Kiewisz","year":"2015","journal-title":"BioMed Res Int"},{"key":"B14","article-title":"Addressing activation of WNT beta-catenin pathway in diverse landscape of endometrial carcinogenesis","volume":"13","author":"De","year":"2021","journal-title":"Am J Transl Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20030755","article-title":"mTOR signaling in cancer and mTOR inhibitors in solid tumor targeting therapy","volume":"20","author":"Tian","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24098342","article-title":"Association of membranous WNT-1 and nuclear mTOR with endometrial cancer grade","volume":"24","author":"Pietrus","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10102144","article-title":"CD133 expression in the nucleus is associated with endometrial carcinoma staging and tumor angioinvasion","volume":"10","author":"Pietrus","year":"2021","journal-title":"J Clin Med"},{"key":"B18","first-page":"395","article-title":"Association of the immunohistochemical detection of gamma-glutamyl transferase expression with clinicopathological findings in postmenopausal women with endometrioid adenocarcinoma of the uterus","volume":"67","author":"Pitynski","year":"2016","journal-title":"J Physiol Pharmacol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2013.03.007","article-title":"The role of miRNAs in regulating gene expression networks","volume":"425","author":"Gurtan","year":"2013","journal-title":"J Mol Biol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11060832","article-title":"The use of microRNAs in the management of endometrial cancer: A meta-analysis","volume":"11","author":"Delangle","year":"2019","journal-title":"Cancers"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.27601","article-title":"Diagnostic value of microRNA panel in endometrial cancer: A systematic review","volume":"11","author":"Donkers","year":"2020","journal-title":"Oncotarget"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/cells11111836","article-title":"Clinical value and molecular function of circulating microRNAs in endometrial cancer regulation: A systematic review","volume":"11","author":"Bloomfield","year":"2022","journal-title":"Cells"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073416","article-title":"The role of mTOR and eIF signaling in benign endometrial diseases","volume":"23","author":"Driva","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2174\/1389450120666191120123612","article-title":"The potential of PI3K\/AKT\/mTOR signaling as a druggable target for endometrial and ovarian carcinomas","volume":"21","author":"Lengyel","year":"2020","journal-title":"Curr Drug Targets"},{"key":"B25","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S1470-2045(17)30904-X","article-title":"Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy","volume":"19","author":"Denkert","year":"2018","journal-title":"Lancet Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nature14404","article-title":"Melanoma-intrinsic \u03b2-catenin signalling prevents anti-tumour immunity","volume":"523","author":"Spranger","year":"2015","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.04.014","article-title":"The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment","volume":"30","author":"Delgoffe","year":"2009","journal-title":"Immunity"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(25)00167-6","article-title":"ESGO\u2013ESTRO\u2013ESP guidelines for the management of patients with endometrial carcinoma: update 2025","volume":"26","author":"Concin","year":"2025","journal-title":"Lancet Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20038","article-title":"Prognostic significance and interobserver variability of histologic grading systems for endometrial carcinoma","volume":"100","author":"Scholten","year":"2004","journal-title":"Cancer"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31827f576a","article-title":"Poor interobserver reproducibility in the diagnosis of high-grade endometrial carcinoma","volume":"37","author":"Gilks","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2015.43","article-title":"Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative","volume":"28","author":"Stelloo","year":"2015","journal-title":"Mod Pathol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s44276-025-00145-2","article-title":"Next-generation sequencing outperforms Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) in endometrial cancer molecular classification","volume":"3","author":"Yoshimura","year":"2025","journal-title":"BJC Rep"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2015.190","article-title":"A clinically applicable molecular-based classification for endometrial cancers","volume":"113","author":"Talhouk","year":"2015","journal-title":"Br J Cancer"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0000000000000518","article-title":"Endometrial carcinoma diagnosis: use of FIGO grading and genomic subcategories in clinical practice: recommendations of the international society of gynecological pathologists","volume":"38","author":"Soslow","year":"2018","journal-title":"Int J Gynecol Pathol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-014-0409-7","article-title":"The role of Wnt signaling members in the uterus and embryo during pre-implantation and implantation","volume":"32","author":"Tepekoy","year":"2015","journal-title":"J Assist Reprod Genet"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3880196","article-title":"Mutational analysis of the CTNNB1 and APC genes in uterine endometrioid carcinoma","volume":"13","author":"Schlosshauer","year":"2000","journal-title":"Mod Pathol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/mc.23308","article-title":"Inhibiting Wnt\/beta-catenin in CTNNB1-mutated endometrial cancer","volume":"60","author":"Moroney","year":"2021","journal-title":"Mol Carcinog"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0b013e31827c7708","article-title":"Overexpression of Wnt7a is associated with tumor progression and unfavorable prognosis in endometrial cancer","volume":"23","author":"Liu","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1997.196","article-title":"Expression and hormone regulation of Wnt2, 3, 4, 5a, 7a, 7b and 10b in normal human endometrium and endometrial carcinoma","volume":"75","author":"Bui","year":"1997","journal-title":"Br J Cancer"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3892\/or.2012.2138","article-title":"Expression and the clinical significance of Wnt10a and Wnt10b in endometrial cancer are associated with the Wnt\/\u03b2-catenin pathway","volume":"29","author":"Chen","year":"2013","journal-title":"Oncol Rep"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2013.00085","article-title":"Role of PI3K-AKT-mTOR and Wnt signaling pathways in transition of G1-S phase of cell cycle in cancer cells","volume":"3","author":"Vadlakonda","year":"2013","journal-title":"Front Oncol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1808575115","article-title":"mTORC1 signaling suppresses Wnt\/\u03b2-catenin signaling through DVL-dependent regulation of Wnt receptor FZD level","volume":"115","author":"Zeng","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-020-0380-6","article-title":"Wnt signaling in cancer: Therapeutic targeting of Wnt signaling beyond \u03b2-catenin and the destruction complex","volume":"52","author":"Jung","year":"2020","journal-title":"Exp Mol Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.4161\/cc.10.22.18329","article-title":"The expanding relevance of nuclear mTOR in carcinogenesis","volume":"10","author":"Back","year":"2011","journal-title":"Cell Cycle"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1101\/gad.299958.117","article-title":"Nuclear mTOR acts as a transcriptional integrator of the androgen signaling pathway in prostate cancer","volume":"31","author":"Audet-Walsh","year":"2017","journal-title":"Genes Dev"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.18632\/oncoscience.154","article-title":"mTOR pathway activation in multiple myeloma cell lines and primary tumour cells: Pomalidomide enhances cytoplasmic-nuclear shuttling of mTOR protein","volume":"2","author":"Guglielmelli","year":"2015","journal-title":"Oncoscience"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-025-04297-3","article-title":"PI3K\/AKT\/mTOR pathway and its role in breast cancer stem cells","volume":"398","author":"Prabhu","year":"2025","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1186\/s40169-018-0198-1","article-title":"The role of CD133 in cancer: A concise review","volume":"7","author":"Glumac","year":"2018","journal-title":"Clin Transl Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27968","article-title":"Signal transducer and activator of transcription 3-mediated CD133 up-regulation contributes to promotion of hepatocellular carcinoma","volume":"62","author":"Won","year":"2015","journal-title":"Hepatology"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603597","article-title":"Stat3 activation in human endometrial and cervical cancers","volume":"96","author":"Chen","year":"2007","journal-title":"Br J Cancer"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/freae.2024.1424163","article-title":"Interplay between epigenetics and metabolism controls cancer stem cell plasticity","volume":"2","author":"Choi","year":"2024","journal-title":"Front Epigenet Epigenomics"},{"key":"B52","article-title":"SOX-2, but not Oct4, is highly expressed in early-stage endometrial adenocarcinoma and is related to tumour grading","volume":"8","author":"Pity\u0144ski","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-012-0445-z","article-title":"Predictive value of Sox2 expression in transurethral resection specimens in patients with T1 bladder cancer","volume":"30","author":"Ruan","year":"2013","journal-title":"Med Oncol"},{"key":"B54","article-title":"Elevated expression of SOX2 and FGFR1 in correlation with poor prognosis in patients with small cell lung cancer","volume":"6","author":"Yang","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1021\/bi00076a003","article-title":"Extracellular glutathione is a source of cysteine for cells that express gamma-glutamyl transpeptidase","volume":"32","author":"Hanigan","year":"1993","journal-title":"Biochemistry"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1177\/44.10.8813074","article-title":"Immunohistochemical detection of gamma-glutamyl transpeptidase in normal human tissue","volume":"44","author":"Hanigan","year":"1996","journal-title":"J Histochem Cytochem"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2005.10.005","article-title":"Expression of gamma-glutamyltransferase in cancer cells and its significance in drug resistance","volume":"71","author":"Pompella","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1007\/s10162-012-0317-4","article-title":"Atoh1, an essential transcription factor in neurogenesis and intestinal and inner ear development: function, regulation, and context dependency","volume":"13","author":"Mulvaney","year":"2012","journal-title":"J Assoc Res Otolaryngol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jcmgh.2016.10.001","article-title":"Transcriptional regulation by ATOH1 and its target SPDEF in the intestine","volume":"3","author":"Lo","year":"2016","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/377355a0","article-title":"Signalling downstream of activated mammalian Notch","volume":"377","author":"Jarriault","year":"1995","journal-title":"Nature"},{"key":"B61","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/71657","article-title":"Control of endodermal endocrine development by Hes-1","volume":"24","author":"Jensen","year":"2000","journal-title":"Nat Genet"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/nature03659","article-title":"Notch\/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells","volume":"435","author":"van Es","year":"2005","journal-title":"Nature"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.592616","article-title":"Functional gene expression differentiation of the Notch signaling pathway in female reproductive tract tissues\u2014a comprehensive review with analysis","volume":"8","author":"Orzechowska","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.6001\/actamedica.v26i3.4148","article-title":"Changes in the expression of Notch and Wnt signalling molecules in human endometrial cancer","volume":"26","author":"Lachej","year":"2019","journal-title":"Acta Med Litu"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/8199306","article-title":"Components of NOTCH signaling for uterine cancer patients' prognosis","volume":"2022","author":"Lachej","year":"2022","journal-title":"J Oncol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0208221","article-title":"Mismatch repair deficiency and aberrations in the Notch and Hedgehog pathways are of prognostic value in patients with endometrial cancer","volume":"13","author":"Polychronidou","year":"2018","journal-title":"PloS One"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-052016-100127","article-title":"The varied roles of Notch in cancer","volume":"12","author":"Aster","year":"2017","journal-title":"Annu Rev Pathol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2012.111","article-title":"Expression of miRNAs and PTEN in endometrial specimens ranging from histologically normal to hyperplasia and endometrial adenocarcinoma","volume":"25","author":"Lee","year":"2012","journal-title":"Mod Pathol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011213","article-title":"The prognostic value of microRNA-183 in human cancers: A meta-analysis","volume":"97","author":"Zhang","year":"2018","journal-title":"Medicine"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3390\/biom11020274","article-title":"Low expression of miR-375 and miR-190b differentiates grade 3 patients with endometrial cancer","volume":"11","author":"Pietrus","year":"2021","journal-title":"Biomolecules"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28563","article-title":"The emerging role of miR-375 in cancer","volume":"135","author":"Yan","year":"2014","journal-title":"Int J Cancer"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201901764R","article-title":"miR-190b promotes tumor growth and metastasis via suppressing NLRC3 in bladder carcinoma","volume":"34","author":"Chen","year":"2020","journal-title":"FASEB J"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1009168","article-title":"In vivo miRNA knockout screening identifies miR-190b as a novel tumor suppressor","volume":"16","author":"Hong","year":"2020","journal-title":"PloS Genet"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C800074200","article-title":"The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2","volume":"283","author":"Korpal","year":"2008","journal-title":"J Biol Chem"},{"key":"B75","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11864-017-0504-y","article-title":"Immunotherapy in gynecologic cancers: Are we there yet","volume":"18","author":"Pakish","year":"2017","journal-title":"Curr Treat Options Oncol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2009.03.022","article-title":"Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer","volume":"114","author":"de Jong","year":"2009","journal-title":"Gynecol Oncol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.62347\/BXZM8857","article-title":"Immune cell infiltration as a prognostic factor in endometrial cancer: a meta-analysis","volume":"15","author":"Lin","year":"2025","journal-title":"Am J Cancer Res"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2108330","article-title":"Lenvatinib plus pembrolizumab for advanced endometrial cancer","volume":"386","author":"Makker","year":"2022","journal-title":"N Engl J Med"},{"key":"B79","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s42047-024-00164-2","article-title":"Predictive biomarkers in endometrial carcinomas: a review of their relevance in daily anatomic pathology","volume":"7","author":"Nagel","year":"2024","journal-title":"Surg Exp Pathol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17152420","article-title":"Predictive biomarkers for immunotherapy in endometrial carcinoma","volume":"17","author":"Pizzimenti","year":"2025","journal-title":"Cancers"},{"key":"B81","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41523-020-0156-0","article-title":"Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer","volume":"6","author":"Kos","year":"2020","journal-title":"NPJ Breast Cancer"},{"key":"B82","doi-asserted-by":"publisher","first-page":"30801","DOI":"10.1038\/s41598-024-81040-7","article-title":"A machine learning-based immune response signature to facilitate prognosis prediction in patients with endometrial cancer","volume":"14","author":"Wang","year":"2024","journal-title":"Sci Rep"},{"key":"B83","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12943-025-02555-9","article-title":"Notch signaling in the tumor microenvironment: recent advances and targeted therapeutics","volume":"25","author":"Chen","year":"2026","journal-title":"Mol Cancer"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1352484","article-title":"Novel insights into Notch signaling in tumor immunity: potential targets for cancer immunotherapy","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.iotech.2025.101076","article-title":"Harnessing TCR repertoires: predictive insights and therapeutic monitoring in cancer immunotherapy","volume":"28","author":"Chiffelle","year":"2025","journal-title":"Immunooncol Technol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"4098","DOI":"10.1038\/s41467-021-24343-x","article-title":"The T cell receptor repertoire of tumor infiltrating T cells is predictive and prognostic for cancer survival","volume":"12","author":"Valpione","year":"2021","journal-title":"Nat Commun"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.64898\/2026.06.08.26355191","article-title":"Integrated T-cell receptor repertoire and tumor immunogenicity profiling reveals distinct immunogenomic states in endometrial cancer","author":"Aversa","year":"2026"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgc.2025.101656","article-title":"Circulating tumor DNA in endometrial cancer: clinical significance and implications","volume":"35","author":"Capasso","year":"2025","journal-title":"Int J Gynecol Cancer"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15101289","article-title":"The application of circulating tumour DNA (ctDNA) in the diagnosis, prognosis, and treatment monitoring of gynaecological and breast cancers (Review)","volume":"15","author":"Englisz","year":"2025","journal-title":"Diagnostics (Basel)"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2025.36.e5","article-title":"Selective utilization of circulating tumor DNA testing enables disease monitoring in endometrial and ovarian carcinomas","volume":"36","author":"Jamieson","year":"2025","journal-title":"J Gynecol Oncol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1007\/s40291-021-00559-x","article-title":"Commercial ctDNA assays for minimal residual disease detection of solid tumors","volume":"25","author":"Chen","year":"2021","journal-title":"Mol Diagn Ther"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.10503","article-title":"Feasibility of pap-derived ctDNA for detection of sporadic and Lynch-associated endometrial cancer","volume":"43","author":"Latham","year":"2025","journal-title":"J Clin Oncol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3390\/ijms262311708","article-title":"Minimal residual disease detection: Bridging molecular and clinical strategies for recurrence prevention in gynecologic cancers","volume":"26","author":"Putra","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1668","article-title":"Integrated single-cell RNA sequencing and spatial transcriptomics analysis reveals the tumour microenvironment in patients with endometrial cancer responding to anti-PD-1 treatment","volume":"14","author":"Chen","year":"2024","journal-title":"Clin Transl Med"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2021.10.013","article-title":"A multi-omic single-cell landscape of human gynecologic Malignancies","volume":"81","author":"Regner","year":"2021","journal-title":"Mol Cell"},{"key":"B96","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s40164-025-00724-6","article-title":"Spatial ecostructural modelling of endometrial cancer identifies the key role of CD90+CD105+ endothelial cells in tumour heterogeneity and predicts disease recurrence","volume":"14","author":"Wu","year":"2025","journal-title":"Exp Hematol Oncol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1685565","article-title":"Navigating tumour microenvironment in endometrial carcinoma: a comprehensive review integrating immunohistochemistry, single-cell RNA-sequencing and spatial transcriptomics","volume":"15","author":"Mondal","year":"2025","journal-title":"Front Oncol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02993-w","article-title":"Prediction of recurrence risk in endometrial cancer with multimodal deep learning","volume":"30","author":"Volinsky-Fremond","year":"2024","journal-title":"Nat Med"},{"key":"B99","doi-asserted-by":"publisher","first-page":"4973","DOI":"10.1038\/s41467-024-49017-2","article-title":"AI-based histopathology image analysis reveals a distinct subset of endometrial cancers","volume":"15","author":"Darbandsari","year":"2024","journal-title":"Nat Commun"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1701427","article-title":"Deep learning-based automated detection of endometrioid endometrial carcinoma in histopathology","volume":"15","author":"Li","year":"2026","journal-title":"Front Oncol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.14923","article-title":"FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek","year":"2023","journal-title":"Int J Gynaecol Obstet"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1906951\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:40:45Z","timestamp":1790336445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1906951\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":101,"alternative-id":["10.3389\/fonc.2026.1906951"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1906951","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"article-number":"1906951"}}